EORTC Mobile Devices (EMBED): Defining an Implementation Strategy for the Digital Assessment of Quality of Life and Objective Patient Measures in EORTC Clinical Trials

In line with the aim of the Quality of Life Group (QLG) to “investigate the use of new technologies to administer PRO/ HRQoL instruments in clinical trials, research studies and in routine clinical practice”, this study will position the European Organisation for Research and Treatment of Cancer (EORTC) and QLG in the rapidly evolving field of smart devices in oncology, with potential benefits in relation with the current trends in the pharmaceutical field.

Principal Investigator

Quality of Life Department, EORTC Headquarters, Brussels, Belgium
Dr. Andrew Bottomley

The project is funded by the EORTC.